Table 1.
Comparison of characteristics between patients with and without calcification on chest CT
| Characteristics | All, n = 304 | Any Calcification n = 204 | No Calcification n = 100 | P Value |
|---|---|---|---|---|
| Age, y | 70.7 ± 9.6 | 73.6 ± 8.8 | 64.8 ± 8.6 | <0.001 |
| Female, no. (%) | 190 (62.5) | 120 (58.8) | 70 (70.0) | 0.059 |
| Nonwhite, no. (%) | 32 (14) | 17 (11.3) | 15 (19.5) | 0.091 |
| BMI, mean, kg/m2 | 27.1 ± 6.1 | 27.1 ± 6.7 | 27.1 ± 5.8 | 0.960 |
| Any smoking history, no. (%) | 167 (59.9) | 118 (64.1) | 49 (51.6) | 0.043 |
| Comorbid conditions, no. (%) | ||||
| Hypertension | 129 (44.6) | 72 (37.5) | 57(58.8) | 0.001 |
| Dyslipidemia | 165 (56.9) | 124 (64.6) | 41 (41.8) | <0.001 |
| Diabetes | 62 (21.4) | 45 (23.4) | 17 (17.3) | 0.231 |
| Chronic kidney disease | 40 (13.8) | 26 (13.6) | 14 (14.3) | 0.875 |
| Known coronary artery disease | 27 (12.5) | 24 (12.5) | 3 (3.1) | 0.009 |
| Medications, n = 290 | ||||
| Aspirin | 112 (38.6) | 82 (42.7) | 30 (30.6) | 0.083 |
| Statin | 151 (52.1) | 118 (61.5) | 33 (33.7) | <0.001 |
| β‐Blocker | 105 (36.2) | 84 (43.8) | 21 (21.4) | <0.001 |
| Other lipid‐lowering drugs | 25 (8.6) | 16 (8.3) | 9 (9.1) | 0.73 |
Abbreviations: BMI, body mass index; CT, computed tomography.